secwatch.observer — SEC 8-K summary
======================================

Issuer:     Insight Molecular Diagnostics Inc. (IMDX)
CIK:        0001642380
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001641172-25-005288
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncocyte terminates Marcum as auditor, engages CBIZ CPAs for FY 2025
--------------------------------------------------------------------

- Terminated Marcum LLP effective April 11, 2025; engaged CBIZ CPAs P.C. on April 16, 2025 as auditor for FY 2025.
- Change follows CBIZ CPAs' acquisition of Marcum's attest business effective November 1, 2024.
- No disagreements or reportable events occurred during Marcum's tenure through April 11, 2025.
- Marcum's reports for FY 2023 and 2024 were unqualified except for a going-concern note in 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642380/000164117225005288/0001641172-25-005288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642380/000164117225005288/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer